What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q4 2022?

213 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock
Shares outstanding: 48,932,355
Total 13F shares: 30,053,540
Share change: +4,477,856
Total reported value: $2,317,913,385
Put/Call ratio: 80%
Price per share: $77.13
Number of holders: 213
Value change: +$384,566,478
Number of buys: 111
Number of sells: 96

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 05464T104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.4%	3,111,500	$138,835,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	4.5%	2,192,255	$97,819,000	—	30 Sep 2022	13F
Fairmount Funds Management LLC	13F	Company	3.9%	1,896,647	$84,628,000	—	30 Sep 2022	13F
RTW INVESTMENTS, LP	13F	Company	3.8%	1,882,164	$83,982,000	—	30 Sep 2022	13F
PFM Health Sciences, LP	13F	Company	3.4%	1,659,733	$74,057,000	—	30 Sep 2022	13F
Avidity Partners Management LP	13F	Company	3.1%	1,538,600	$68,652,000	—	30 Sep 2022	13F
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	788,263	$35,172,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	1.5%	711,332	$31,740,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.4%	693,524	$30,945,000	—	30 Sep 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.3%	617,900	$27,571,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	1.2%	599,531	$26,752,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	562,589	$25,102,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	1.1%	531,337	$23,708,000	—	30 Sep 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	1.1%	520,080	$23,206,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	519,264	$23,170,000	—	30 Sep 2022	13F
Bellevue Group AG	13F	Company	1%	496,524	$22,155,000	—	30 Sep 2022	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	0.82%	401,108	$17,897,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.72%	351,140	$15,668,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	0.71%	348,896	$15,568,000	—	30 Sep 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.61%	300,000	$13,386,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.59%	287,943	$12,848,000	—	30 Sep 2022	13F
Atika Capital Management LLC	13F	Company	0.54%	264,330	$11,795,000	—	30 Sep 2022	13F
NORGES BANK	13F	Company	0.52%	256,397	$11,440,434	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.46%	226,353	$10,100,000	—	30 Sep 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.44%	213,793	$9,539,000	—	30 Sep 2022	13F
WMS Partners, LLC	13F	Company	0.4%	194,000	$8,656,000	—	30 Sep 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.37%	182,870	$8,159,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.35%	171,878	$7,670,000	—	30 Sep 2022	13F
Invesco Ltd.	13F	Company	0.35%	171,050	$7,632,000	—	30 Sep 2022	13F
US BANCORP \DE\	13F	Company	0.31%	150,406	$6,711,000	—	30 Sep 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.31%	150,000	$6,693,000	—	30 Sep 2022	13F
SEI INVESTMENTS CO	13F	Company	0.3%	148,783	$6,638,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.29%	141,312	$6,305,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.28%	135,130	$6,031,000	—	30 Sep 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.27%	133,798	$5,970,000	—	30 Sep 2022	13F
Squarepoint Ops LLC	13F	Company	0.27%	132,593	$5,916,000	—	30 Sep 2022	13F
WCM INVESTMENT MANAGEMENT, LLC	13F	Company	0.27%	133,705	$5,903,000	—	30 Sep 2022	13F
MOODY ALDRICH PARTNERS LLC	13F	Company	0.25%	122,261	$5,455,000	—	30 Sep 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.25%	121,810	$5,435,000	—	30 Sep 2022	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.23%	112,572	$5,023,000	—	30 Sep 2022	13F
S.c.a. Candriam	13F	Individual	0.23%	110,380	$4,925,000	—	30 Sep 2022	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.22%	106,839	$4,767,000	—	30 Sep 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.22%	106,582	$4,756,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	87,572	$3,907,000	—	30 Sep 2022	13F
MORGAN JESS S & CO INC	13F	Company	0.16%	78,895	$3,520,000	—	30 Sep 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.15%	75,833	$3,384,000	—	30 Sep 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.15%	73,822	$3,294,000	—	30 Sep 2022	13F
ACT CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	73,000	$3,257,000	—	30 Sep 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.14%	70,000	$3,123,000	—	30 Sep 2022	13F
Swiss National Bank	13F	Company	0.14%	69,200	$3,088,000	—	30 Sep 2022	13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q4 2022

As of 31 Dec 2022, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 213 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,053,540 shares. The largest 10 holders included VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., Fairmount Funds Management LLC, BVF INC/IL, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., ALETHEA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and FMR LLC. This page lists 214 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

180

Q4 2022 holders

213

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.